Stay updated on ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2; removed a government funding/operating status notice. These edits are administrative and do not affect study details or eligibility.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding notice about potential delays. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedThe update adds a 'Show glossary' option and updates metadata labels (Last Update Submitted that Met QC Criteria, Revision: v3.4.0, No FEAR Act Data), while removing older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4 with no substantive changes to the study content, eligibility criteria, or listed locations.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a dedicated Locations section and listed Cornwall and Norfolk as locations. Removed the separate Cornwall Locations and Norfolk Locations subsections in the prior revision.SummaryDifference0.3%

- Check92 days agoChange DetectedThe page revision now shows Revision: v3.3.2 instead of v3.2.0. This appears to be a minor metadata update with no observable changes to the study details or eligibility criteria.SummaryDifference0.1%

Stay in the know with updates to ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page.